At a glance
- Originator Daiichi Pharmaceutical
- Class Antihypertensives; Benzopyrans; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 27 Dec 2000 Discontinued-Preclinical for Angina pectoris in Japan (Unknown route)
- 27 Dec 2000 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
- 10 Jul 1998 No-Development-Reported for Angina pectoris in Japan (Unknown route)